NCT04073810View on ClinicalTrials.gov

Residual Inflammation and Plaque Progression Long-term Evaluation

Active, not recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

December 1, 2024

Study Completion Date

April 1, 2025

Conditions
AtherosclerosisMyocardial InfarctionCoronary Artery DiseaseInflammation
Interventions
DIAGNOSTIC_TEST

PET imaging

Coronary 68Ga-DOTATATE PET-MRI or PET-CT at baseline and 3 months

DIAGNOSTIC_TEST

Coronary CT angiography

CTCA at baseline and 2 years

DIAGNOSTIC_TEST

Cardiac MRI

Cardiac MRI at 1 year

Trial Locations (1)

Unknown

University of Cambridge, Cambridge

All Listed Sponsors
collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

Wellcome Trust

OTHER

lead

University of Cambridge

OTHER